As of 2024-09-14, the Relative Valuation of TG Therapeutics Inc (TGTX) is 15.69 USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.73 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -33.9%.
The range of the Relative Valuation is 1.63 - 35.28 USD.
| Range | Selected | |
| Trailing P/E multiples | 38.4x - 57.1x | 47.8x |
| Forward P/E multiples | 24.2x - 31.4x | 27.8x |
| Fair Price | 1.63 - 35.28 | 15.69 |
| Upside | -93.1% - 48.7% | -33.9% |
| Date | P/E |
| 2024-09-13 | 38.41 |
| 2024-09-12 | 37.53 |
| 2024-09-11 | 37.34 |
| 2024-09-10 | 38.08 |
| 2024-09-09 | 38.44 |
| 2024-09-06 | 35.66 |
| 2024-09-05 | 34.73 |
| 2024-09-04 | 35.74 |
| 2024-09-03 | 36.59 |
| 2024-08-30 | 38.02 |
| 2024-08-29 | 38.05 |
| 2024-08-28 | 37.79 |
| 2024-08-27 | 37.40 |
| 2024-08-26 | 38.80 |
| 2024-08-23 | 39.59 |
| 2024-08-22 | 39.49 |
| 2024-08-21 | 40.58 |
| 2024-08-20 | 39.99 |
| 2024-08-19 | 40.77 |
| 2024-08-16 | 35.74 |
| 2024-08-15 | 33.89 |
| 2024-08-14 | 33.76 |
| 2024-08-13 | 34.36 |
| 2024-08-12 | 33.42 |
| 2024-08-09 | 32.24 |
| 2024-08-08 | 32.43 |
| 2024-08-07 | 32.35 |
| 2024-08-06 | 33.31 |
| 2024-08-05 | 27.85 |
| 2024-08-02 | 29.94 |
| 2024-08-01 | 30.64 |
| 2024-07-31 | 31.98 |
| 2024-07-30 | 31.09 |
| 2024-07-29 | 32.06 |
| 2024-07-26 | 33.28 |
| 2024-07-25 | 32.34 |
| 2024-07-24 | 31.69 |
| 2024-07-23 | 32.81 |
| 2024-07-22 | 33.08 |
| 2024-07-19 | 33.99 |
| 2024-07-18 | 34.36 |
| 2024-07-17 | 35.74 |
| 2024-07-16 | 36.45 |
| 2024-07-15 | 34.43 |
| 2024-07-12 | 34.30 |
| 2024-07-11 | 34.62 |
| 2024-07-10 | 33.18 |
| 2024-07-09 | 32.22 |
| 2024-07-08 | 31.64 |
| 2024-07-05 | 30.77 |